Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: Possible implication for TLR4-signalling and chronic immune activation

Innate Immunity

Volumn 19, Issue 3, 2013, Pages 290-297

  Trøseid, Marius ^a   Lind, Andreas ^a,b   Nowak, Piotr ^c   Barqasho, Babilonia ^a   Heger, Bernt ^a   Lygren, Idar ^d   Pedersen, Karin K ^d   Kanda, Tatsuo ^d   Funaoka, Hiroyuki ^e,f   Damås, Jan K ^g,h   Kvale, Dag ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^f DS Pharma Biomedical Co Ltd   (Japan)

^g NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^h TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

HIV infection; HMGB1; LPS; MD2; TLR4

Indexed keywords

AMINOSALICYLIC ACID; CD14 ANTIGEN; CD38 ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; PROTEIN MD 2; STEROID; TOLL LIKE RECEPTOR 4; LIPOPOLYSACCHARIDE; LY96 PROTEIN, HUMAN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; BLOOD; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; METABOLISM; MIDDLE AGED;

ADULT; ANTIGENS, CD38; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV; HIV INFECTIONS; HIV SEROPOSITIVITY; HMGB1 PROTEIN; HUMANS; IMMUNITY; INFLAMMATORY BOWEL DISEASES; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84877728149     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425912461042     Document Type: Article

References (47)

1. Lane HC, Masur H, Edgar LC, et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 ; 309: 453-458
2. Hazenberg MD, Stuart JW, Otto SA, et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood. 2000 ; 95: 249-255
3. Hellerstein M, Hanley MB, Cesar D, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med. 1999 ; 5: 83-89
4. Valdez H, Lederman MM. Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev. 1997 ;: 187-228
5. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis. 1999 ; 179: 859-870
6. Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 2008 ; 1: 23-30
7. da Silva CJ, Ulevitch RJ. MD2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J Biol Chem. 2002 ; 277: 1845-1854
8. Latz E, Visintin A, Lien E, et al. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem. 2002 ; 277: 47 834-47843
9. Kim HM, Park BS, Kim JI, et al. Crystal structure of the TLR4-MD2 complex with bound endotoxin antagonist Eritoran. Cell. 2007 ; 130: 906-917
10. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006 ; 12: 1365-1371
11. Agresti A, Bianchi ME. HMGB proteins and gene expression. Curr Opin Genet Dev. 2003 ; 13: 170-178
12. Beyer C, Stearns NA, Giessl A, et al. The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death. Innate Immun. Epub ahead of print 16 February. DOI: 10.1177/1753425912437981.
13. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007 ; 81: 1-5
14. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002 ; 418: 191-195
15. Tsung A, Klune JR, Zhang X, et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med. 2007 ; 204: 2913-2923
16. Bianchi ME. HMGB1 loves company. J Leukoc Biol. 2009 ; 86: 573-576
17. Lindkvist A, Nowak P, Troseid M, et al. HMGB1 and bacterial products synergistically induce HIV-1 replication in vitro. In: 17th conference on retroviruses and opportunistic infections, San Fransisco, CA, USA, 19 February 2010, abstract no. 245. Available at: www.retroconference.org.
18. Troseid M, Nowak P, Nystrom J, et al. Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy. AIDS. 2010 ; 24: 1733-1737
19. Troseid M, Sonnerborg A, Nowak P. High mobility group box protein-1 in HIV-1 infection. Curr HIV Res. 2011 ; 9: 6-10
20. Youn JH, Oh YJ, Kim ES, et al. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J Immunol. 2008 ; 180: 5067-5074
21. Okulicz JF, Marconi VC, Landrum ML, et al. Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. J Infect Dis. 2009 ; 200: 1714-1723
22. Cario E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis. 2010 ; 16: 1583-1597
23. Holm M, Pettersen FO, Kvale D. PD-1 predicts CD4 loss rate in chronic HIV-1 infection better than HIV RNA and CD38 but not in cryopreserved samples. Curr HIV Res. 2008 ; 6: 49-58
24. Sandanger O, Ryan L, Bohnhorst J, et al. IL-10 enhances MD2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients. J Immunol. 2009 ; 182: 588-595
25. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011 ; 203: 780-790
26. Funaoka H, Kanda T, Kajiura S, et al. Development of a high-specificity sandwich ELISA system for the quantification of human intestinal fatty acid-binding protein (I-FABP) concentrations. Immunol Invest. 2011 ; 40: 223-242
27. Gutierrez A, Frances R, Amoros A, et al. Cytokine association with bacterial DNA in serum of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009 ; 15: 508-514
28. Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004 ; 279: 7370-7377
29. Yu M, Wang H, Ding A, et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock. 2006 ; 26: 174-179
30. Yang H, Hreggvidsdottir HS, Palmblad K, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A. 2010 ; 107: 11 942-11947
31. Hreggvidsdottir HS, Lundberg AM, Aveberger AC, et al. High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Mol Med. 2012 ; 18: 224-230
32. Visintin A, Iliev DB, Monks BG, et al. MD2. Immunobiology. 2006 ; 211: 437-447
33. Viriyakosol S, Tobias PS, Kitchens RL, Kirkland TN. MD2 binds to bacterial lipopolysaccharide. J Biol Chem. 2001 ; 276: 38 044-38051
34. Qin YH, Dai SM, Tang GS, et al. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. J Immunol. 2009 ; 183: 6244-6250
35. Schiraldi M, Raucci A, Munoz LM, et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med. 2012 ; 209: 551-563
36. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999 ; 17: 657-700
37. Gougeon ML, Melki MT, Saidi H. HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells. Cell Death Differ. 2012 ; 19: 96-106
38. Saidi H, Melki MT, Gougeon ML. HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk. PLoS One. 2008 ; 3: e3601 - e3601
39. Sachsenberg N, Perelson AS, Yerly S, et al. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med. 1998 ; 187: 1295-1303
40. Barqasho B, Nowak P, Abdurahman S, et al. Implications on the release of HMGB1 from dying cells during HIV-1 infection in vitro. J Gen Virol. 2010 ; 91: 1800-1809
41. Dumitriu IE, Baruah P, Manfredi AA, et al. HMGB1: guiding immunity from within. Trends Immunol. 2005 ; 26: 381-387
42. Bonaldi T, Talamo F, Scaffidi P, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 2003 ; 22: 5551-5560
43. Kamat A, Ancuta P, Blumberg RS, Gabuzda D. Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation. PLoS One. 2010 ; 5: e15533 - e15533
44. Gregson JN, Steel A, Bower M, et al. Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individuals. AIDS. 2009 ; 23: 29-34
45. Seksik P, Sokol H, Grondin V, et al. Sera from patients with Crohn's disease break bacterial lipopolysaccharide tolerance of human intestinal epithelial cells via MD2 activity. Innate Immun. 2010 ; 16: 381-390
46. Prendergast A, Prado JG, Kang YH, et al. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS. 2010 ; 24: 491-502
47. Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr. 2007 ; 86: 1286-1292